![]()
|
|
||||||||
in Vascular Smooth
Muscle Cells
(Received for publication, January 29, 1997, and in revised form, March 13, 1997)
,
,
From the Departments of § Pharmacology,
Recently, we have designed farnesyltransferase
and geranylgeranyltransferase I inhibitors (FTI-277 and GGTI-298) that
selectively block protein farnesylation and geranylgeranylation,
respectively. In this study, we describe the opposing effects of these
inhibitors on interleukin-1
Pediatrics, and ¶ Chemistry, University of
Pittsburgh, Pittsburgh, Pennsylvania 15261
(IL-1
)-stimulated induction of
nitric-oxide synthase-2 (NOS-2) in rat pulmonary artery smooth muscle
cells (RPASMC) and rat hepatocytes. Pretreatment of cells with GGTI-298 caused a superinduction of NOS-2 by IL-1
. RPASMC treated with GGTI-298 (10 µM) prior to IL-1
(10 ng/ml)
expressed levels of NOS-2 protein five times higher than those exposed
to IL-1
alone. This superinduction of NOS-2 protein by pretreatment
with GGTI-298 resulted in nitrite concentrations in the medium that
were 5-fold higher at 10 ng/ml IL-1
and 10-fold higher at 1 ng/ml
IL-1
. Furthermore, NOS-2 mRNA levels in RPASMC were also
increased 6- and 14-fold (at 10 and 1 ng/ml IL-1
, respectively) when
the cells were pretreated with GGTI-298. In contrast, treatment of
cells with the inhibitor of protein farnesylation, FTI-277 (10 µM), blocked IL-1
-induced NOS-2 expression at mRNA
and protein levels. Pretreatment with lovastatin, an inhibitor of
protein prenylation, resulted in superinduction of NOS-2. This
superinduction was reversed by geranylgeraniol, but not by farnesol,
further confirming that inhibition of geranylgeranylation, not
farnesylation, is responsible for enhanced NOS-2 expression. The
results demonstrate that a farnesylated protein(s) mediates IL-1
induction of NOS-2, whereas a geranylgeranylated protein(s) represses
this induction.
This article has been cited by other articles:
![]() |
W. W. Polk, M. E. Ellis, J. V. Kushleika, P. L. Simmonds, and J. S. Woods RhoA regulation of NF-{kappa}B activation is mediated by COX-2-dependent feedback inhibition of IKK in kidney epithelial cells Am J Physiol Cell Physiol, September 1, 2007; 293(3): C1160 - C1170. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Lee, H. Qin, and E. N. Benveniste Simvastatin inhibits IFN-{gamma}-induced CD40 gene expression by suppressing STAT-1{alpha} J. Leukoc. Biol., August 1, 2007; 82(2): 436 - 447. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Habib, I. Shamseddeen, M. S. Nasrallah, T. A. Antoun, G. Nemer, J. Bertoglio, R. Badreddine, and K. F. Badr Modulation of COX-2 expression by statins in human monocytic cells FASEB J, June 1, 2007; 21(8): 1665 - 1674. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S. Zuckerbraun, D. A. Stoyanovsky, R. Sengupta, R. A. Shapiro, B. A. Ozanich, J. Rao, J. E. Barbato, and E. Tzeng Nitric oxide-induced inhibition of smooth muscle cell proliferation involves S-nitrosation and inactivation of RhoA Am J Physiol Cell Physiol, February 1, 2007; 292(2): C824 - C831. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Madonna, P. Di Napoli, M. Massaro, A. Grilli, M. Felaco, A. De Caterina, D. Tang, R. De Caterina, and Y.-J. Geng Simvastatin Attenuates Expression of Cytokine-inducible Nitric-oxide Synthase in Embryonic Cardiac Myoblasts J. Biol. Chem., April 8, 2005; 280(14): 13503 - 13511. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-J. Na, S.-J. Lee, Y.-C. Kang, Y.-L. Cho, W.-D. Nam, P. K. M. Kim, K.-S. Ha, H.-T. Chung, H. Lee, Y.-G. Kwon, et al. Inhibition of Farnesyltransferase Prevents Collagen-Induced Arthritis by Down-Regulation of Inflammatory Gene Expression through Suppression of p21ras-Dependent NF-{kappa}B Activation J. Immunol., July 15, 2004; 173(2): 1276 - 1283. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Monick, L. S. Powers, N. S. Butler, and G. W. Hunninghake Inhibition of Rho Family GTPases Results in Increased TNF-{alpha} Production After Lipopolysaccharide Exposure J. Immunol., September 1, 2003; 171(5): 2625 - 2630. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. C. Kraynack, D. A. Corey, H. L. Elmer, and T. J. Kelley Mechanisms of NOS2 regulation by Rho GTPase signaling in airway epithelial cells Am J Physiol Lung Cell Mol Physiol, September 1, 2002; 283(3): L604 - L611. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Begum, O. A. Sandu, and N. Duddy Negative Regulation of Rho Signaling by Insulin and Its Impact on Actin Cytoskeleton Organization in Vascular Smooth Muscle Cells: Role of Nitric Oxide and Cyclic Guanosine Monophosphate Signaling Pathways Diabetes, July 1, 2002; 51(7): 2256 - 2263. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hattori, N. Nakanishi, and K. Kasai Statin enhances cytokine-mediated induction of nitric oxide synthesis in vascular smooth muscle cells Cardiovasc Res, June 1, 2002; 54(3): 649 - 658. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Degraeve, M. Bolla, S. Blaie, C. Creminon, I. Quere, P. Boquet, S. Levy-Toledano, J. Bertoglio, and A. Habib Modulation of COX-2 Expression by Statins in Human Aortic Smooth Muscle Cells. INVOLVEMENT OF GERANYLGERANYLATED PROTEINS J. Biol. Chem., December 7, 2001; 276(50): 46849 - 46855. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. B. Lobell, C. A. Omer, M. T. Abrams, H. G. Bhimnathwala, M. J. Brucker, C. A. Buser, J. P. Davide, S. J. deSolms, C. J. Dinsmore, M. S. Ellis-Hutchings, et al. Evaluation of Farnesyl:Protein Transferase and Geranylgeranyl:Protein Transferase Inhibitor Combinations in Preclinical Models Cancer Res., December 1, 2001; 61(24): 8758 - 8768. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Finder, J. L. Petrus, A. Hamilton, R. T. Villavicencio, B. R. Pitt, and S. M. Sebti Signal transduction pathways of IL-1{beta}-mediated iNOS in pulmonary vascular smooth muscle cells Am J Physiol Lung Cell Mol Physiol, October 1, 2001; 281(4): L816 - L823. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. A. Sandu, M. Ito, and N. Begum Signal Transduction in Smooth Muscle: Selected Contribution: Insulin utilizes NO/cGMP pathway to activate myosin phosphatase via Rho inhibition in vascular smooth muscle J Appl Physiol, September 1, 2001; 91(3): 1475 - 1482. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. D. Chan, K. R. Morris, J. T. Belisle, P. Hill, L. K. Remigio, P. J. Brennan, and D. W. H. Riches Induction of Inducible Nitric Oxide Synthase-NO{middle dot} by Lipoarabinomannan of Mycobacterium tuberculosis Is Mediated by MEK1-ERK, MKK7-JNK, and NF-{kappa}B Signaling Pathways Infect. Immun., April 1, 2001; 69(4): 2001 - 2010. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. D. Chan and D. W. H. Riches IFN-{gamma} + LPS induction of iNOS is modulated by ERK, JNK/SAPK, and p38mapk in a mouse macrophage cell line Am J Physiol Cell Physiol, March 1, 2001; 280(3): C441 - C450. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Chen, U. Ikeda, M. Shimpo, M. Ikeda, S. Minota, and K. Shimada Fluvastatin Upregulates Inducible Nitric Oxide Synthase Expression in Cytokine-Stimulated Vascular Smooth Muscle Cells Hypertension, December 1, 2000; 36(6): 923 - 928. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Hernandez-Perera, D. Perez-Sala, E. Soria, and S. Lamas Involvement of Rho GTPases in the Transcriptional Inhibition of Preproendothelin-1 Gene Expression by Simvastatin in Vascular Endothelial Cells Circ. Res., September 29, 2000; 87(7): 616 - 622. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Sadeghi, M. Collinge, R. Pardi, and J. R. Bender Simvastatin Modulates Cytokine-Mediated Endothelial Cell Adhesion Molecule Induction: Involvement of an Inhibitory G Protein J. Immunol., September 1, 2000; 165(5): 2712 - 2718. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Muniyappa, R. Xu, J. L. Ram, and J. R. Sowers Inhibition of Rho protein stimulates iNOS expression in rat vascular smooth muscle cells Am J Physiol Heart Circ Physiol, June 1, 2000; 278(6): H1762 - H1768. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Boota, B. Johnson, K.-L Lee, M. A. Blaskovich, S.-X. Liu, V. E. Kagan, A. Hamilton, B. Pitt, S. M. Sebti, and P. Davies Prenyltransferase inhibitors block superoxide production by pulmonary vascular smooth muscle Am J Physiol Lung Cell Mol Physiol, February 1, 2000; 278(2): L329 - L334. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sun, M. A. Blaskovich, D. Knowles, Y. Qian, J. Ohkanda, R. D. Bailey, A. D. Hamilton, and S. M. Sebti Antitumor Efficacy of a Novel Class of Non-thiol-containing Peptidomimetic Inhibitors of Farnesyltransferase and Geranylgeranyltransferase I: Combination Therapy with the Cytotoxic Agents Cisplatin, Taxol, and Gemcitabine Cancer Res., October 1, 1999; 59(19): 4919 - 4926. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sun, Y. Qian, Z. Chen, J. Marfurt, A. D. Hamilton, and S. M. Sebti The Geranylgeranyltransferase I Inhibitor GGTI-298 Induces Hypophosphorylation of Retinoblastoma and Partner Switching of Cyclin-dependent Kinase Inhibitors. A POTENTIAL MECHANISM FOR GGTI-298 ANTITUMOR ACTIVITY J. Biol. Chem., March 12, 1999; 274(11): 6930 - 6934. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. D. Chan, B. W. Winston, S.-T. Uh, M. W. Wynes, D. M. Rose, and D. W. H. Riches Evaluation of the Role of Mitogen-Activated Protein Kinases in the Expression of Inducible Nitric Oxide Synthase by IFN-{gamma} and TNF-{alpha} in Mouse Macrophages J. Immunol., January 1, 1999; 162(1): 415 - 422. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Da Silva, B. Pierrat, J.-L. Mary, and W. Lesslauer Blockade of p38 Mitogen-activated Protein Kinase Pathway Inhibits Inducible Nitric-oxide Synthase Expression in Mouse Astrocytes J. Biol. Chem., November 7, 1997; 272(45): 28373 - 28380. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Vogt, J. Sun, Y. Qian, A. D. Hamilton, and S. M. Sebti The Geranylgeranyltransferase-I Inhibitor GGTI-298 Arrests Human Tumor Cells in G0/G1 and Induces p21WAF1/CIP1/SDI1 in a p53-independent Manner J. Biol. Chem., October 24, 1997; 272(43): 27224 - 27229. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |